Aktive Positionen von Renee T. Leck
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ORCHARD THERAPEUTICS PLC | Investor Relations Kontakt | - | - |
Karriereverlauf von Renee T. Leck
Ehemalige bekannte Positionen von Renee T. Leck
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AGIOS PHARMACEUTICALS, INC. | Public Communications Contact | 01.05.2015 | 01.12.2018 |
Statistik
International
Vereinigte Staaten | 2 |
Vereinigtes Königreich | 2 |
Operativ
Public Communications Contact | 1 |
Investor Relations Contact | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AGIOS PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Orchard Therapeutics Plc
Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Renee T. Leck
- Erfahrung